Renal carcinoma (clear and non-clear cell)

Clinical trials for Renal carcinoma (clear and non-clear cell) explained in plain language.

Never miss a new study

Get alerted when new Renal carcinoma (clear and non-clear cell) trials appear

Sign up with your email to follow new studies for Renal carcinoma (clear and non-clear cell), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New cancer drug EXS74539 enters first human trials

Disease control Recruiting now

This early-stage trial is testing an experimental oral drug called EXS74539 (REC-4539) in about 40 people with various solid tumors, including lung, prostate, ovarian, and breast cancers. The main goal is to check the drug's safety, find the right dose, and see how the body proce…

Matched conditions: RENAL CARCINOMA (CLEAR AND NON-CLEAR CELL)

Phase 1 • Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:06 UTC

Renal carcinoma (clear and non-clear cell)

Get alerted when new Renal carcinoma (clear and non-clear cell) trials appear

New cancer drug EXS74539 enters first human trials